Cargando…
A fluorescence-based high throughput-screening assay for the SARS-CoV RNA synthesis complex
The Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) emergence in 2003 introduced the first serious human coronavirus pathogen to an unprepared world. To control emerging viruses, existing successful anti(retro)viral therapies can inspire antiviral strategies, as conserved viral enzymes (eg....
Autores principales: | Eydoux, Cecilia, Fattorini, Veronique, Shannon, Ashleigh, Le, Thi-Tuyet-Nhung, Didier, Bruno, Canard, Bruno, Guillemot, Jean-Claude |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7833800/ https://www.ncbi.nlm.nih.gov/pubmed/33166547 http://dx.doi.org/10.1016/j.jviromet.2020.114013 |
Ejemplares similares
-
Remdesivir and SARS-CoV-2: Structural requirements at both nsp12 RdRp and nsp14 Exonuclease active-sites
por: Shannon, Ashleigh, et al.
Publicado: (2020) -
Toward the identification of viral cap-methyltransferase inhibitors by fluorescence screening assay
por: Aouadi, Wahiba, et al.
Publicado: (2017) -
Rapid incorporation of Favipiravir by the fast and permissive viral RNA polymerase complex results in SARS-CoV-2 lethal mutagenesis
por: Shannon, Ashleigh, et al.
Publicado: (2020) -
A dual mechanism of action of AT-527 against SARS-CoV-2 polymerase
por: Shannon, Ashleigh, et al.
Publicado: (2022) -
Kill or corrupt: Mechanisms of action and drug-resistance of nucleotide analogues against SARS-CoV-2
por: Shannon, Ashleigh, et al.
Publicado: (2023)